Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
NCT ID: NCT00316212
Last Updated: 2016-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
160 participants
INTERVENTIONAL
2006-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INS50589 Intravenous Infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to receive allogeneic blood product transfusions during and after surgery
Exclusion Criteria
* Have had previous median sternotomy
* Have tendency for bleeding or family history of bleeding
* Have an abnormally low platelet count
* Have received certain anticoagulant or antiplatelet medications within a specified time period prior to the scheduled CABG surgery
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baptist Medical Center Princeton
Birmingham, Alabama, United States
Cardiology, P.C.
Birmingham, Alabama, United States
Sharp Memorial Hospital
San Diego, California, United States
Memorial Medical Center
Springfield, Illinois, United States
St. John's Hospital
Springfield, Illinois, United States
Southern Illinois University School of Medicine
Springfield, Illinois, United States
Lutheran Hospital of Indiana
Fort Wayne, Indiana, United States
Veterans Affairs Medical Center
Lexington, Kentucky, United States
University of Kentucky, Chandler Medical Center
Lexington, Kentucky, United States
St. Mary's of Michigan
Saginaw, Michigan, United States
Covenant Medical Center
Saginaw, Michigan, United States
Viahealth Rochester General Hospital
Rochester, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
The Brody School of Medicine, East Carolina University
Greenville, North Carolina, United States
Cardiac, Vascular, & Thoracic Surgeons, Inc.
Cincinnati, Ohio, United States
Good Samaritan Hospital
Cincinnati, Ohio, United States
Bethesda North Hospital
Cincinnati, Ohio, United States
Oklahoma Cardiovascular Associates
Oklahoma City, Oklahoma, United States
Oklahoma Cardiovascular Research Group
Oklahoma City, Oklahoma, United States
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, United States
CardioThoracic Surgery Center, PLC
Jackson, Tennessee, United States
Jackson Madison County General Hospital
Jackson, Tennessee, United States
Centennial Medical Center
Nashville, Tennessee, United States
The Methodist Hospital
Houston, Texas, United States
Winchester Medical Center
Winchester, Virginia, United States
FHS Research Center, St. Joseph Medical Center
Tacoma, Washington, United States
Northwest Cardiovascular Associates
Tacoma, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
025-102
Identifier Type: -
Identifier Source: org_study_id